Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Cleveland researchers launch Amyvid study

A team of radiologists and neurologists at University Hospitals Case Medical Center in Cleveland are enrolling patients with suspected early-stage Alzheimer’s disease in a study designed to determine if Amyvid can identify amyloid plaques via PET or MRI. Read more about the research by clicking the link below.

Healthcare reform launches new era for nuclear medicine

While healthcare reform has been slowly evolving as a result of many acts of Congress during the past decade, it is the Affordable Care Act of 2010 (ACA), that is driving major changes in healthcare coverage, the economics of the medical industry and quality of care. The latter is being carried by a series of reporting and incentive programs that have a direct impact on the practice of nuclear medicine and molecular imaging, according to a review published March 1 in the Journal of Nuclear Medicine Technology.

MITA receives FDA award for collaborative efforts to mitigate radiation dose in computed tomography imaging equipment

The Medical Imaging & Technology Alliance (MITA) announced today that the Computed Tomography (CT) Nomenclature Working Group, led by the American Association of Physicists in Medicine (AAPM), has received the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) Director’s Special Citation Award for developing CT imaging radiation safety instructional materials through a collaboration of end-users, CT manufacturers and the FDA. The award is MITA’s second recognition from the FDA.

Image-guided brachytherapy cuts cervical cancer morbidity

Image-guided brachytherapy could deliver targeted high doses of radiotherapy while sparing cervical cancer patients from serious side effects, according to preliminary findings presented in April at the 2nd ESTRO Forum in Geneva.

The first century of the American Cancer Society

The American Cancer Society celebrated the 100th anniversary of its founding in May.

African American prostate cancer patients experience longer treatment delays

African American men experience longer prostate cancer treatment delays than Caucasian men, according to a study published online May 28 in Cancer.

Dynamic susceptibility contrast MRI could tip off early-stage Alzheimer’s

Cerebral blood flow (CBF) is an emerging indication of Alzheimer’s pathology and dynamic susceptibility contrast (DSC) MRI may be an ideal modality to track CBF in high-risk patients with mild cognitive impairment, as well as those already diagnosed with the disease, according to a study published in the June issue of Academic Radiology.

High-res detectors improve SPECT/CT evaluation of skeletal disease

SPECT/CT using high-resolution CT detector technology has been found to increase the diagnostic capabilities of SPECT when used to detect diseased bone, including osteomyelitis and other peripheral skeletal disease, and at a lower cost than high-resolution multi-detector CT, according to a study published May 23 in the Journal of Nuclear Medicine.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.